Imaginal Exposure II Study: In-Vivo
In-vivo IE II
In-Vivo Treatment for Imaginal Exposure Therapy
1 other identifier
interventional
43
1 country
1
Brief Summary
The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 16, 2018
CompletedFirst Posted
Study publicly available on registry
May 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedMarch 5, 2024
March 1, 2024
3.6 years
October 16, 2018
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
EDEQ (Eating Disorder Examination Questionnaire) at 1-10 Weeks and at 1 year
The EDE-Q is a 41-item self-report questionnaire version of the Eating Disorder Examination, which is a semi-structured interview designed to assess eating disorders symptom frequency and severity over the past 28 days. The EDE-Q uses a 7-point forced-choice rating scheme (No days; 1-5 days; 6-12 days; 13-15 days; 16-22 days; 23-27 days; Everyday). The EDE-Q has four subscales with the question stem "How many days out of the past 28 days...": Restraint (e.g. Have you been consciously trying to restrict the amount of food you eat to influence your shape or weight?), Eating Concern (e.g. Have you had a definite fear that you might not be able to either resist eating or stop eating?), Weight Concern (e.g. Has your weight influenced how you think about (judge) yourself as a person?), and Shape Concern (e.g. How dissatisfied have you felt about your shape?).
1 year and 10 weeks
SUDS (Subjective Units of Distress Scale) at 1-10 Weeks and at 1 year
The SUDS scale is a self-report behavioral measure used during exposure treatment and behavioral assessment to measure anxiety. The SUDS scale has been shown to be a valid and reliable measure of state anxiety. SUDS ratings can range from 0 (completely calm) to 100 (highest anxiety). Other reference points used in this study include 25 (noticeable, but not bothersome anxiety), 50 (bothersome anxiety), and 75 (very bothersome anxiety). Subjective anxiety was assessed both in terms of categorical response and overall change. Categorical response was defined as a drop of at least five points in average SUDS across the exposure across visits.
1 year and 10 weeks
Body Mass Index (BMI) at 1-10 Weeks and at 1 year
Participants will be weighed at 1-10 Weeks and at 1 year and BMI will be calculated in order to see if the BMI of an individual has changed over time.
1 year and 10 weeks
Study Arms (1)
Imaginal Exposure Session
EXPERIMENTALAll participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.
Interventions
All participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.
Eligibility Criteria
You may qualify if:
- Must be at least 18 years of age (no age limit)
- Must currently meet criteria for anorexia, sub-clinical anorexia, bulimia, or sub-clinical bulimia (using the eating disorder diagnostic scale), OR have met criteria for one of these eating disorders in the last year, OR endorse significant eating disorder fears
- Must have at least one significant eating disorder related fear.
You may not qualify if:
- Under 18 years of age
- Individuals who have binge eating disorder or an unspecified eating disorder, OR who do not meet eating disorder related criteria
- Individuals who meet criteria for mania, psychosis, or suicidal ideation
- Participants who are not able to secure transportation to complete therapy sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eating Anxiety Treatment Laboratory and Clinic
Louisville, Kentucky, 40205-1016, United States
Related Publications (3)
Levinson CA, Rapp J, Riley EN. Addressing the fear of fat: extending imaginal exposure therapy for anxiety disorders to anorexia nervosa. Eat Weight Disord. 2014 Dec;19(4):521-4. doi: 10.1007/s40519-014-0115-6. Epub 2014 Apr 2. No abstract available.
PMID: 24691784BACKGROUNDSteinglass JE, Albano AM, Simpson HB, Wang Y, Zou J, Attia E, Walsh BT. Confronting fear using exposure and response prevention for anorexia nervosa: A randomized controlled pilot study. Int J Eat Disord. 2014 Mar;47(2):174-80. doi: 10.1002/eat.22214. Epub 2013 Nov 8.
PMID: 24488838BACKGROUNDSteinglass JE, Sysko R, Glasofer D, Albano AM, Simpson HB, Walsh BT. Rationale for the application of exposure and response prevention to the treatment of anorexia nervosa. Int J Eat Disord. 2011 Mar;44(2):134-41. doi: 10.1002/eat.20784.
PMID: 20127936BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Professor
Study Record Dates
First Submitted
October 16, 2018
First Posted
May 2, 2019
Study Start
May 1, 2017
Primary Completion
December 13, 2020
Study Completion
October 1, 2022
Last Updated
March 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share